News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
754,686 Results
Type
Article (46233)
Company Profile (295)
Press Release (708141)
Multimedia
Podcasts (104)
Webinars (22)
Section
Business (209599)
Career Advice (2128)
Deals (36246)
Drug Delivery (141)
Drug Development (83185)
Employer Resources (175)
FDA (17198)
Job Trends (15333)
News (355171)
Policy (33836)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (2)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (2773)
Accelerated approval (48)
Adcomms (29)
Allergies (174)
Alliances (51430)
ALS (217)
Alzheimer's disease (1840)
Antibody-drug conjugate (ADC) (453)
Approvals (17556)
Artificial intelligence (688)
Autoimmune disease (304)
Automation (58)
Bankruptcy (366)
Best Places to Work (11904)
BIOSECURE Act (20)
Biosimilars (224)
Biotechnology (199)
Bladder cancer (190)
Brain cancer (72)
Breast cancer (760)
Cancer (5896)
Cardiovascular disease (516)
Career advice (1802)
Career pathing (44)
CAR-T (342)
CDC (57)
Celiac Disease (3)
Cell therapy (929)
Cervical cancer (48)
Clinical research (72002)
Collaboration (2124)
Company closure (5)
Compensation (1405)
Complete response letters (83)
COVID-19 (2828)
CRISPR (113)
C-suite (1136)
Cystic fibrosis (155)
Data (7939)
Decentralized trials (3)
Denatured (32)
Depression (165)
Dermatology (86)
Diabetes (599)
Diagnostics (7108)
Digital health (56)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (330)
Drug pricing (213)
Drug shortages (32)
Duchenne muscular dystrophy (285)
Earnings (93201)
Editorial (67)
Employer branding (21)
Employer resources (154)
Events (122640)
Executive appointments (1104)
FDA (20955)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (16)
Frontotemporal dementia (34)
Funding (1774)
Gene editing (247)
Generative AI (59)
Gene therapy (750)
GLP-1 (1096)
Government (4900)
Grass and pollen (6)
Guidances (410)
Healthcare (19677)
HIV (82)
Huntington's disease (57)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (99)
Immunology and inflammation (301)
Immuno-oncology (96)
Indications (191)
Infectious disease (3169)
Inflammatory bowel disease (220)
Inflation Reduction Act (15)
Influenza (138)
Intellectual property (288)
Interviews (331)
IPO (16858)
IRA (52)
Job creations (3730)
Job search strategy (1497)
JPM (60)
Kidney cancer (20)
Labor market (101)
Layoffs (573)
Leadership (41)
Legal (8156)
Liver cancer (101)
Longevity (33)
Lung cancer (772)
Lymphoma (436)
Machine learning (62)
Management (60)
Manufacturing (1067)
MASH (189)
Medical device (14548)
Medtech (14674)
Mergers & acquisitions (20634)
Metabolic disorders (1531)
mRNA (217)
Multiple sclerosis (192)
NASH (18)
Neurodegenerative disease (425)
Neuropsychiatric disorders (107)
Neuroscience (3385)
Neurotech (1)
NextGen: Class of 2026 (6807)
Non-profit (4671)
Now hiring (78)
Obesity (719)
Opinion (302)
Ovarian cancer (223)
Pain (259)
Pancreatic cancer (304)
Parkinson's disease (370)
Partnered (33)
Patents (595)
Patient recruitment (680)
Peanut (64)
People (60907)
Pharmaceutical (60)
Pharmacy benefit managers (34)
Phase 1 (22479)
Phase 2 (31709)
Phase 3 (23570)
Pipeline (8791)
Policy (327)
Postmarket research (2636)
Preclinical (9674)
Press Release (69)
Prostate cancer (301)
Psychedelics (55)
Radiopharmaceuticals (325)
Rare diseases (1112)
Real estate (6132)
Recruiting (71)
Regulatory (26219)
Reports (56)
Research institute (2554)
Resumes & cover letters (370)
Rett syndrome (39)
RNA editing (23)
RSV (89)
Schizophrenia (179)
Series A (300)
Series B (221)
Service/supplier (12)
Sickle cell disease (113)
Special edition (25)
Spinal muscular atrophy (167)
Sponsored (48)
Startups (3773)
State (2)
Stomach cancer (18)
Supply chain (127)
Tariffs (88)
The Weekly (69)
Vaccines (1129)
Venture capital (113)
Weight loss (470)
Women's health (126)
Worklife (20)
Date
Last 7 days (865)
Last 30 days (3476)
Last 365 days (30569)
2026 (12636)
2025 (30761)
2024 (35859)
2023 (40857)
2022 (52033)
2021 (56681)
2020 (55267)
2019 (48053)
2018 (36193)
2017 (33190)
2016 (32700)
2015 (38833)
2014 (32598)
2013 (27793)
2012 (29965)
2011 (30592)
2010 (28740)
Location
Africa (788)
Alabama (94)
Alaska (7)
Arizona (355)
Arkansas (15)
Asia (41558)
Australia (6820)
California (13372)
Canada (3781)
China (1367)
Colorado (576)
Connecticut (597)
Delaware (405)
Europe (91390)
Florida (2022)
Georgia (439)
Hawaii (3)
Idaho (66)
Illinois (1069)
India (93)
Indiana (603)
Iowa (24)
Japan (541)
Kansas (134)
Kentucky (52)
Louisiana (41)
Maine (76)
Maryland (1610)
Massachusetts (9615)
Michigan (363)
Minnesota (734)
Mississippi (7)
Missouri (156)
Montana (36)
Nebraska (29)
Nevada (145)
New Hampshire (87)
New Jersey (3504)
New Mexico (31)
New York (3516)
North Carolina (1718)
North Dakota (10)
Northern California (6699)
Ohio (405)
Oklahoma (24)
Oregon (44)
Pennsylvania (2684)
Puerto Rico (29)
Rhode Island (50)
South America (1164)
South Carolina (85)
South Dakota (2)
Southern California (5265)
Tennessee (212)
Texas (2128)
United States (47394)
Utah (397)
Vermont (1)
Virginia (329)
Washington D.C. (81)
Washington State (1097)
West Virginia (4)
Wisconsin (128)
Wyoming (2)
754,686 Results for "cardiovascular systems inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
NextGen
Corsera Eyes Two-Pronged Approach To Tackle Leading Cardiovascular Killer
Corsera Health’s Chief Operating Officer Rena Denoncourt and CFO Meredith Kaya speak with
BioSpace
about the biotech’s mission and vision for the next generation of cardiovascular care.
February 24, 2026
·
2 min read
·
Annalee Armstrong
Collaboration
Lilly Fronts $100M for CSL’s IL-6 Blocker to Bolster I&I, Cardiovascular Pipeline
CSL is advancing clazakizumab for the treatment of cardiovascular events in end-stage kidney disease and will retain rights over the asset in this indication. Lilly will explore other conditions.
February 18, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Starlight Cardiovascular Announces First Baby in the World Treated with Lifeline Stent System at Cincinnati Children’s Hospital
March 24, 2026
·
2 min read
Press Releases
CardioPharma Reviews Applications to Explore Non-Cardiovascular Benefits of CVD Polypill
May 12, 2026
·
4 min read
Press Releases
Reprieve Cardiovascular Announces Publication of FASTR Pilot Trial Results in JACC: Heart Failure
May 8, 2026
·
5 min read
Approvals
Novo Secures Cardiovascular Expansion for Semaglutide Pill
Rybelsus can now be used as a primary or secondary prevention pill to lower the risk of major adverse cardiovascular events in at-risk patients with type 2 diabetes.
October 20, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Medtronic completes acquisition of CathWorks, expanding its leadership in transforming care for patients with cardiovascular disease
April 20, 2026
·
6 min read
Press Releases
American College of Cardiology (ACC) Scientific Sessions 2026 Underscore the Need for Complementary Therapies Including Icosapent Ethyl (IPE) in Treatment of Elevated Triglycerides and Cardiovascular Risk Reduction
April 8, 2026
·
15 min read
Cardiovascular disease
Amgen, Merck, Novo, More Take Cardiovascular Benefits to New Heights at AHA 2025
Data presented at this year’s American Heart Association Scientific Sessions in New Orleans underline rapid advancements in the cardiovascular field.
November 11, 2025
·
5 min read
·
Tristan Manalac
Press Releases
Immutrin appoints leading cardiovascular drug development expert Dr. Robert Blaustein as Chief Medical Officer and establishes US subsidiary
May 6, 2026
·
3 min read
1 of 75,469
Next
